Blandt de patienter, som i forvejen fik topikal IOP- sænkende medicin (22 patienter), steg den gennemsnitlige IOP en smule i forhold til baseline i AZOPT gruppen.
Among patients who were on topical IOP-lowering medicinal products (22 patients), mean IOP increased slightly from baseline in the AZOPT group.